DEA’s suspension of McKesson Corporation Retraction

Posted in Latest News on January 19, 2017.

The previous post, regarding the DEA’s suspension of McKesson Corporation’s sales of controlled substances from distribution in Florida, was found to be confusing. This suspension will impact one distribution center in Florida and impacts only the handling of hydromorphone. The Florida Department of Health and Division of Medical Quality Assurance apologizes for any confusion that may have resulted from that message. For specific details about McKesson’s agreement with the DEA, please contact the DEA. For questions about the potential impact of the sanctions in Florida, please contact the DOH’s Medical Quality Assurance.



More Latest News

Board Chairs/Vice Chairs Annual Long-range Planning Meeting
January 11, 2019

The Annual Long Range Planning meeting has been scheduled for Friday, May 31, 2019. Please click here for more information. Continue reading


Dental Sedation Workshop
December 11, 2018

Click here for more information about the Dental Sedation Workshop that will take place on February 14, 2019. Continue reading